Biosimilars Market Research Analysis And Forecast Report till 2022

In this report, the United States Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
with sales (volume), revenue (value), market share and growth rate of Biosimilars in these regions, from 2012 to 2022 (forecast).

Request a Free Sample Copy of this Report @ http://bit.ly/2oksDKG

United States Biosimilars market competition by top manufacturers/players, with Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
• Pfizer
• Sandoz International GmbH
• Teva Pharmaceuticals Industries
• Amgen Inc
• Biocon
• Dr. Reddy's Laboratories
• F. Hoffmann-La Roche
• Celltrion
• Samsung Bioepis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
• Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
• Peptides (Glucagon, Calcitonin)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
• Oncology
• Blood Disorders

Download Full Research Report @ http://bit.ly/2BFDuqu

Table of Contents

United States Biosimilars Market Report 2017
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars by Product Category
1.2.1 United States Biosimilars Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Biosimilars Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.5 Peptides (Glucagon, Calcitonin)
1.3 United States Biosimilars Market by Application/End Users
1.3.1 United States Biosimilars Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 United States Biosimilars Market by Region
1.4.1 United States Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Biosimilars Status and Prospect (2012-2022)
1.4.3 Southwest Biosimilars Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Biosimilars Status and Prospect (2012-2022)

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: [email protected]
visit our website: http://www.radiantinsights.com/
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco
State: California
Country: United States